MedTrace Logo

Impact of Vitamin D Therapies on Chronic Kidney Disease

NCT01222234 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2016-05-16

Study results available
· View outcomes & findings →

Summary

This investigation will consist of a prospective study utilizing two separate populations of patients with 25(OH)D deficiency, one population with chronic kidney disease (CKD) and one with normal renal function.

Conditions

  • Chronic Kidney Disease (CKD)
  • End-stage Renal Disease (ESRD)

Interventions

DRUG

Cholecalciferol - CKD

Cholecalciferol tablet 50,000 IU twice weekly for 8 weeks

DEVICE

Calcitriol - CKD

Calcitriol 0.25 mcg once daily for 8 weeks

DRUG

Cholecalciferol - non-CKD

Cholecalciferol tablet 50,000 IU twice weekly for 8 weeks

Sponsors & Collaborators

  • University of Kansas Medical Center

    lead OTHER

Principal Investigators

  • Jason Stubbs, MD · University of Kansas Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2012-08-31
Completion
2012-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01222234 on ClinicalTrials.gov